Invasive infections caused by non-Aspergillus moulds identified by sequencing analysis at a tertiary care hospital in Taiwan, 2000-2008

Clinical Microbiology and Infection

Volumn 16, Issue 8, 2010, Pages 1204-1206

  Hsiue, H C ^a   Ruan, S Y ^b   Kuo, Y L ^b   Huang, Y T ^b   Hsueh, P R ^b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Fusarium; Invasive infection; Paecilomyces; Scedosporium; Zygomycetes

Indexed keywords

AMPHOTERICIN B; ANIDULAFUNGIN; CASPOFUNGIN; ELONGATION FACTOR 1; ELONGATION FACTOR 1ALPHA; ELONGATION FACTOR 2; FLUCONAZOLE; INTERNAL TRANSCRIBED SPACER; INTERNAL TRANSCRIBED SPACER 1; INTERNAL TRANSCRIBED SPACER 4; ITRACONAZOLE; MICAFUNGIN; POSACONAZOLE; UNCLASSIFIED DRUG; VORICONAZOLE; ANTIFUNGAL AGENT;

ADOLESCENT; ADULT; AGED; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; ASPERGILLUS; CHILD; CONTROLLED STUDY; FEMALE; FUNGAL DETECTION; FUNGUS CULTURE; FUNGUS ISOLATION; FUSARIUM; HUMAN; IMMUNOCOMPROMISED PATIENT; INFANT; LEUKEMIA; LUNG MYCOSIS; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; MORTALITY; MOULD; NONHUMAN; PAECILOMYCES; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SEQUENCE ANALYSIS; SPECIES COMPARISON; SYSTEMIC MYCOSIS; TAIWAN; ZYGOMYCETES; ZYGOMYCOSIS; CLASSIFICATION; DNA SEQUENCE; FUNGUS; GENETICS; HOSPITAL; INCIDENCE; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MIDDLE AGED; MYCOLOGY; MYCOSES; NEWBORN; PROCEDURES; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMPHOTERICIN B; ANTIFUNGAL AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; FUNGI; HOSPITALS; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MYCOLOGY; MYCOSES; SEQUENCE ANALYSIS, DNA; TAIWAN; YOUNG ADULT;

EID: 77955164940     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2009.03103.x     Document Type: Article

References (15)

1. Neofytos D, Horn D, Anaissie E. Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry. Clin Infect Dis 2009, 48:265-273.
2. Caston-Osorio JJ, Rivero A, Torre-Cisneros J. Epidemiology of invasive fungal infection. Int J Antimicrob Agents 2008, 32(suppl 2):s103-s109.
3. Malani AN, Kauffman CA, Malani AN, Kauffman CA. Changing epidemiology of rare mould infections: implications for therapy. Drugs 2007, 67:1803-1812.
4. Bhatti Z, Shaukat A, Almyroudis NG, Segal BH. Review of epidemiology, diagnosis, and treatment of invasive mould infections in allogeneic hematopoietic stem cell transplant recipients. Mycopathologia 2006, 162:1-15.
5. Husain S, Alexander BD, Munoz P. Opportunistic mycelial fungal infections in organ transplant recipients: emerging Importance of Non-Aspergillus mycelial fungi. Clin Infect Dis 2003, 37:221-229.
6. Alastruey-Izquierdo A, Cuenca-Estrella M, Monzón A, Mellado E, Rodríguez-Tudela JL. Antifungal susceptibility profile of clinical Fusarium spp. isolates identified by molecular methods. J Antimicrob Chemother 2008, 61:805-809.
7. Almyroudis NG, Sutton DA, Fothergill AW, Rinaldi MG, Kusne S. In vitro susceptibilities of 217 clinical isolates of zygomycetes to conventional and new antifungal agents. Antimicrob Agents Chemother 2007, 51:2587-2590.
8. Castelli MV, Alastruey-Izquierdo A, Cuesta I. Susceptibility testing and molecular classification of Paecilomyces spp. Antimicrob Agents Chemother 2008, 52:2926-2928.
9. Pagano L, Caira M, Nosari A. Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study - Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne. Clin Infect Dis 2007, 45:1161-1170.
10. Alastruey-Izquierdo A, Cuenca-Estrella M, Monzon A, Rodriguez-Tudela JL. Prevalence and susceptibility testing of new species of Pseudallescheria and Scedosporium in a collection of clinical mold isolates. Antimicrob Agents Chemother 2007, 51:748-751.
11. Ascioglu S, Rex JH, de Pauw B. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002, 34:7-14.
12. Leaw SN, Chang HC, Sun HF, Barton R, Bouchara JP, Chang TC. Identification of medically important yeast species by sequence analysis of the internal transcribed spacer regions. J Clin Microbiol 2006, 44:693-699.
13. Kristensen R, Torp M, Kosiak B, Holst-Jensen A. Phylogeny and toxigenic potential is correlated in Fusarium species as revealed by partial translation elongation factor 1 alpha gene sequences. Mycol Res 2005, 109:173-186.
14. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi; approved standard M38-A2 2008, Wayne, PA, CLSI
15. Wessolossky M, Haran JP, Bagchi K. Paecilomyces lilacinus olecranon bursitis in an immunocompromised host: case report and review. Diagn Microbiol Infect Dis 2008, 61:354-357.